英文名稱 |
中文名稱 |
CAS號(hào) |
操作 |
HLA-A*02:01 VZV IE62 Tetramer-ALWALPHAA-PE |
|
|
詳細(xì)
|
HLA-A*24:02 Adenovirus 5 Hexon37-45 Tetramer-TYFSLNNKF-PE |
|
|
詳細(xì)
|
HLA-A*02:01 PRAME 425-433 Tetramer-SLLQHLIGL-APC |
|
|
詳細(xì)
|
HLA-A*02:01 SARS-CoV-2 Spike Glycoprotein Tetramer-RLNEVAKNL-APC |
|
|
詳細(xì)
|
HLA-A*03:01 HIV nef Tetramer-QVPLRPMTYK-APC |
|
|
詳細(xì)
|
HLA-A*11:01 EBV LMP2 Tetramer-SSCSSCPLTK-PE |
|
|
詳細(xì)
|
HLA-A*24:02 EBV EBNA3A peptide |
|
|
詳細(xì)
|
HLA-A*02:01 SARS-CoV-2 Spike Glycoprotein Tetramer-RLNEVAKNL-BV421 |
|
|
詳細(xì)
|
HLA-A*02:01 SARS-CoV-2 Spike Glycoprotein Tetramer-YLQPRTFLL-APC |
|
|
詳細(xì)
|
HLA-A*02:01 WT1 37-45 Tetramer-VLDFAPPGA-PE |
|
|
詳細(xì)
|
HLA-A*02:01 Survivin Tetramer-LTLGEFLKL-PE |
|
|
詳細(xì)
|
HLA-A*24:02 EBV LMP2 419-427 Tetramer-TYGPVFMSL-APC |
|
|
詳細(xì)
|
HLA-A*23:01 Custom Tetramer-APC (CP) |
|
|
詳細(xì)
|
HLA-A*24:02 EBV BRLF1 peptide |
|
|
詳細(xì)
|
HLA-A*03:01 HIV nef Tetramer-QVPLRPMTYK-PE |
|
|
詳細(xì)
|
HLA-A*24:02 Control Tetramer-AYAAAAAAL-FITC |
|
|
詳細(xì)
|
HLA-A*02:01 Survivin Tetramer-LTLGEFLKL-APC |
|
|
詳細(xì)
|
HLA-A*03:01 gp100 Tetramer-ALLAVGATK-PE |
|
|
詳細(xì)
|
HLA-A*03:01 HPV E6 Tetramer-KLCLRFLSK-BV421 |
|
|
詳細(xì)
|
HLA-A*02:01 SARS-CoV-2 Spike Glycoprotein Tetramer-RLQSLQTYV-PE |
|
|
詳細(xì)
|
HLA-A*02:01 PSA 141-150 Tetramer-FLTPKKLQCV-APC |
|
|
詳細(xì)
|
HLA-A*02:01 topo II Tetramer-FLYDDNQRV-BV421 |
|
|
詳細(xì)
|
HLA-A*02:01 PRAME 100-108 Tetramer-VLDGLDVLL-APC |
|
|
詳細(xì)
|
HLA-A*02:01 SSX-2 Tetramer-KASEKIFYV-APC |
|
|
詳細(xì)
|
HLA-A*02:01 PSA 141-150 Tetramer-FLTPKKLQCV-BV421 |
|
|
詳細(xì)
|
HLA-A*24:02 CA9 219-227 Tetramer-EYRALQLHL-PE |
|
|
詳細(xì)
|
HLA-A*24:02 Adenovirus 5 Hexon37-45 Tetramer-TYFSLNNKF-APC |
|
|
詳細(xì)
|
HLA-A*23:01 Custom Tetramer-BV421 (IP) |
|
|
詳細(xì)
|
HLA-A*24:02 Adenovirus 11 Hexon37-45 Tetramer-TYFNLGNKF-PE |
|
|
詳細(xì)
|
HLA-A*02:01 PSA 141-150 Tetramer-FLTPKKLQCV-PE |
|
|
詳細(xì)
|
HLA-A*02:01 PSMA Tetramer-VLAGGFFLL-BV421 |
|
|
詳細(xì)
|
HLA-A*02:01 RNA-dependent helicase Tetramer-YLLPAIVHI-PE |
|
|
詳細(xì)
|
HLA-A*24:02 ACC-1 Tetramer-DYLQYVLQI-PE |
|
|
詳細(xì)
|
HLA-A*24:02 Adenovirus 11 Hexon696-704 Tetramer-VYSGSIPYL-APC |
|
|
詳細(xì)
|
HLA-A*24:02 EBV LMP2 131-139 Tetramer-PYLFWLAAI-PE |
|
|
詳細(xì)
|
HLA-A*02:01 PSA Tetramer-KLQCVDLHV-APC |
|
|
詳細(xì)
|
HLA-A*02:01 VZV IE62 Tetramer-ALWALPHAA-BV421 |
|
|
詳細(xì)
|
HLA-A*03:01 CMV IE1 184-192 Tetramer-KLGGALQAK-PE |
|
|
詳細(xì)
|
HLA-A*11:01 EBV LMP2 Tetramer-SSCSSCPLSK-APC |
|
|
詳細(xì)
|
HLA-A*23:01 Custom Tetramer-APC (IP) |
|
|
詳細(xì)
|
HLA-A*02:01 PRAME 142-151 Tetramer-SLYSFPEPEA-PE |
|
|
詳細(xì)
|
HLA-A*02:01 SARS-CoV-2 Spike Glycoprotein Tetramer-KLPDDFTGCV-APC |
|
|
詳細(xì)
|
HLA-A*02:01 SARS-CoV-2 Spike Glycoprotein Tetramer-RLNEVAKNL-PE |
|
|
詳細(xì)
|
HLA-A*23:01 Custom Tetramer-PE (IP) |
|
|
詳細(xì)
|
HLA-A*24:02 Adenovirus 11 Hexon696-704 Tetramer-VYSGSIPYL-PE |
|
|
詳細(xì)
|
HLA-A*02:01 PRAME 425-433 Tetramer-SLLQHLIGL-PE |
|
|
詳細(xì)
|
HLA-A*03:01 gp100 Tetramer-ALLAVGATK-APC |
|
|
詳細(xì)
|
HLA-A*02:01 SARS-CoV-2 Spike Glycoprotein Tetramer-KLPDDFTGCV-BV421 |
|
|
詳細(xì)
|
HLA-A*02:01 SARS-CoV-2 Spike Glycoprotein Tetramer-RLQSLQTYV-APC |
|
|
詳細(xì)
|
HLA-A*02:01 topo II Tetramer-FLYDDNQRV-PE |
|
|
詳細(xì)
|
HLA-A*24:02 EBV BMLF1 peptide |
|
|
詳細(xì)
|
HLA-A*02:01 PRAME 100-108 Tetramer-VLDGLDVLL-PE |
|
|
詳細(xì)
|
HLA-A*02:01 PSMA Tetramer-VLAGGFFLL-APC |
|
|
詳細(xì)
|
HLA-A*02:01 SSX-2 Tetramer-KASEKIFYV-PE |
|
|
詳細(xì)
|
HLA-A*03:01 HIV nef Tetramer-QVPLRPMTYK-BV421 |
|
|
詳細(xì)
|
HLA-A*02:01 PSCA Tetramer-AILALLPAL-APC |
|
|
詳細(xì)
|
HLA-A*02:01 PSMA Tetramer-VLAGGFFLL-PE |
|
|
詳細(xì)
|
HLA-A*03:01 HPV E6 Tetramer-KLCLRFLSK-APC |
|
|
詳細(xì)
|
HLA-A*24:02 EBV LMP2 131-139 Tetramer-PYLFWLAAI-APC |
|
|
詳細(xì)
|
HLA-A*24:02 EBV LMP2 peptide |
|
|
詳細(xì)
|
HLA-A*02:01 VZV IE62 Tetramer-ALWALPHAA-APC |
|
|
詳細(xì)
|
HLA-A*11:01 Control Tetramer-ATAAAAAAK-PE |
|
|
詳細(xì)
|
HLA-A*02:01 PRAME 142-151 Tetramer-SLYSFPEPEA-APC |
|
|
詳細(xì)
|
HLA-A*02:01 Survivin (T2M) Tetramer-LMLGEFLKL-APC |
|
|
詳細(xì)
|
HLA-A*02:01 topo II Tetramer-FLYDDNQRV-APC |
|
|
詳細(xì)
|
HLA-A*11:01 CMV pp65 Tetramer-ATVQGQNLK-PE |
|
|
詳細(xì)
|
HLA-A*02:01 PSCA Tetramer-AILALLPAL-BV421 |
|
|
詳細(xì)
|
HLA-A*02:01 RHAMM Tetramer-ILSLELMKL-APC |
|
|
詳細(xì)
|
HLA-A*02:01 SARS-CoV-2 Spike Glycoprotein Tetramer-YLQPRTFLL-PE |
|
|
詳細(xì)
|
HLA-A*23:01 Custom Tetramer-PE (CP) |
|
|
詳細(xì)
|
HLA-A*24:02 Control Tetramer-AYAAAAAAL-APC |
|
|
詳細(xì)
|
HLA-A*02:01 WT1 37-45 Tetramer-VLDFAPPGA-APC |
|
|
詳細(xì)
|
HLA-A*11:01 Control Tetramer-ATAAAAAAK-APC |
|
|
詳細(xì)
|
HLA-A*11:01 EBV LMP2 Tetramer-SSCSSCPLTK-APC |
|
|
詳細(xì)
|
HLA-A*24:02 CA9 219-227 Tetramer-EYRALQLHL-APC |
|
|
詳細(xì)
|
HLA-A*24:02 Control Tetramer-AYAAAAAAL-PE |
|
|
詳細(xì)
|
HLA-A*02:01 PSCA Tetramer-AILALLPAL-PE |
|
|
詳細(xì)
|
HLA-A*02:01 RHAMM Tetramer-ILSLELMKL-PE |
|
|
詳細(xì)
|
HLA-A*02:01 Survivin Tetramer-LTLGEFLKL-BV421 |
|
|
詳細(xì)
|
HLA-A*03:01 HPV E6 Tetramer-KLCLRFLSK-PE |
|
|
詳細(xì)
|
HLA-A*24:02 EBV LMP2 419-427 peptide |
|
|
詳細(xì)
|
HLA-A*02:01 PSA Tetramer-KLQCVDLHV-PE |
|
|
詳細(xì)
|
HLA-A*11:01 EBV LMP2 Tetramer-SSCSSCPLSK-PE |
|
|
詳細(xì)
|
HLA-A*23:01 Custom Tetramer-BV421 (CP) |
|
|
詳細(xì)
|
HLA-A*24:02 Adenovirus 11 Hexon37-45 Tetramer-TYFNLGNKF-APC |
|
|
詳細(xì)
|
HLA-A*24:02 EBV EBNA3B peptide |
|
|
詳細(xì)
|
HLA-A*24:02 EBV LMP2 419-427 Tetramer-TYGPVFMSL-PE |
|
|
詳細(xì)
|
HLA-A*02:01 PRAME 300-309 Tetramer-ALYVDSLFFL-APC |
|
|
詳細(xì)
|
HLA-A*11:01 Control Tetramer-ATAAAAAAK-FITC |
|
|
詳細(xì)
|
HLA-A*02:01 RNA-dependent helicase Tetramer-YLLPAIVHI-APC |
|
|
詳細(xì)
|
HLA-A*11:01 CMV pp65 Monomer-ATVQGQNLK |
|
|
詳細(xì)
|
HLA-A*24:02 ACC-1 Tetramer-DYLQYVLQI-APC |
|
|
詳細(xì)
|
HLA-A*02:01 SARS-CoV-2 Spike Glycoprotein Tetramer-YLQPRTFLL-BV421 |
|
|
詳細(xì)
|
HLA-A*02:01 Survivin (T2M) Tetramer-LMLGEFLKL-PE |
|
|
詳細(xì)
|
HLA-A*03:01 gp100 Tetramer-ALLAVGATK-BV421 |
|
|
詳細(xì)
|
HLA-A*02:01 PRAME 300-309 Tetramer-ALYVDSLFFL-PE |
|
|
詳細(xì)
|
HLA-A*02:01 SARS-CoV-2 Spike Glycoprotein Tetramer-KLPDDFTGCV-PE |
|
|
詳細(xì)
|
HLA-A*02:01 SARS-CoV-2 Spike Glycoprotein Tetramer-RLQSLQTYV-BV421 |
|
|
詳細(xì)
|
HLA-A*03:01 CMV IE1 184-192 Tetramer-KLGGALQAK-APC |
|
|
詳細(xì)
|
HLA-A*24:02 CMV pp65 peptide |
|
|
詳細(xì)
|